Low-density lipoprotein cholesterol versus particle number in middle school children

Journal of Pediatrics

Volumn 163, Issue 2, 2013, Pages

  Mietus Snyder, Michele ^a   Drews, Kimberly L ^b   Otvos, James D ^c   Willi, Steven M ^d   Foster, Gary D ^e   Jago, Russell ^f   Buse, John B ^g  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c LIPOSCIENCE INC   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e TEMPLE UNIVERSITY   (United States)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

apoB; Apolipoprotein B; BMI; Body mass index; Cardiovascular disease; CVD; HDL C; HDL P; High density lipoprotein cholesterol; High density lipoprotein particle; HOMA IR; Homeostatic model of insulin resistance; LDL; LDL C; LDL P; Low density lipoprotein; Low density lipoprotein cholesterol; Low density lipoprotein particle; NMR; Nuclear magnetic resonance; TC; TG; Total cholesterol; Triglycerides; Very low density lipoprotein; Very low density lipoprotein particle; VLDL; VLDL P

Indexed keywords

INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CHILD; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HISPANIC; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE SCHOOL; NEGRO; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84880631281     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.01.012     Document Type: Article

References (35)

1. J.D. Brunzell, M. Davidson, C.D. Furberg, R.B. Goldberg, B.V. Howard, and J.H. Stein Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524
2. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, and National Heart, Lung, and Blood Institute Expert Panel on Integrated Guidelines for Cardiovascular Healthy and Risk Reduction in Children and Adolescents: summary report Pediatrics 128 Suppl 5 2011 S213 S256
3. J. Rodenburg, M.N. Vissers, A. Wiegman, A.S. van Trotsenburg, A. van der Graaf, and E. de Groot Statin treatment in children with familial hypercholesterolemia: the younger, the better Circulation 116 2007 664 668
4. A.D. Sniderman, A.C. St-Pierre, B. Cantin, G.R. Dagenais, J.P. Despres, and B. Lamarche Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk Am J Cardiol 91 2003 1173 1177
5. P. Libby The forgotten majority: unfinished business in cardiovascular risk reduction J Am Coll Cardiol 46 2005 1225 1228
6. J.D. Otvos, S. Mora, I. Shalaurova, P. Greenland, R.H. Mackey, and D.C. Goff Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number J Clin Lipidol 5 2011 105 113
7. W.C. Cromwell, J.D. Otvos, M.J. Keyes, M.J. Pencina, L. Sullivan, and R.S. Vasan LDL Particle number and risk of future cardiovascular disease in the Framingham Offspring Study - Implications for LDL management J Clin Lipidol 1 2007 583 592
8. S.F. Burns, S. Lee, and S.A. Arslanian In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children Diabetes Care 32 2009 2087 2093
9. H.S. Group, G.D. Foster, B. Linder, T. Baranowski, D.M. Cooper, and L. Goldberg A school-based intervention for diabetes risk reduction N Engl J Med 363 2010 443 453
10. A.C. Petersen, L. Crockett, M. Richards, and A. Boxer A self-report measure of pubertal status: reliability, validity, and initial norms J Youth Adolesc 17 1988 117 133
11. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870
12. A. Donner, and N. Klar Design and analysis of cluster randomized trials in health research 2000 Arnold Publishers London
13. J.D. Otvos, E.J. Jeyarajah, and W.C. Cromwell Measurement issues related to lipoprotein heterogeneity Am J Cardiol 90 2002 22i 29i
14. J.R. Fernandez, D.T. Redden, A. Pietrobelli, and D.B. Allison Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents J Pediatr 145 2004 439 444
15. G.E. Duncan Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002 Arch Pediatr Adolesc Med 160 2006 523 528
16. A. Moran, D.R. Jacobs Jr., J. Steinberger, C.P. Hong, R. Prineas, and R. Luepker Insulin resistance during puberty: results from clamp studies in 357 children Diabetes 48 1999 2039 2044
17. I. Tamir, G. Heiss, C.J. Glueck, B. Christensen, P. Kwiterovich, and B.M. Rifkind Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study J Chronic Dis 34 1981 27 39
18. S. Kathiresan, J.D. Otvos, L.M. Sullivan, M.J. Keyes, E.J. Schaefer, and P.W. Wilson Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study Circulation 113 2006 20 29
19. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844
20. V. Ramjee, L.S. Sperling, and T.A. Jacobson Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math J Am Coll Cardiol 58 2011 457 463
21. A. Sniderman, H. Vu, and K. Cianflone Effect of moderate hypertriglyceridemia on the relation of plasma total and LDL apo B levels Atherosclerosis 89 1991 109 116
22. S.R. Daniels Screening and treatment of dyslipidemias in children and adolescents Horm Res Paediatr 76 suppl 1 2001 47 51
23. J.D. Berry, A. Dyer, X. Cai, D.B. Garside, H. Ning, and A. Thomas Lifetime risks of cardiovascular disease N Engl J Med 366 2012 321 329
24. A. Sniderman, P.R. Lawler, K. Williams, G. Thanassoulis, J. De Graff, and C.D. Furberg The causal exposure model of vascular disease Clin Sci 122 2012 369 373
25. R. Weiss, J.D. Otvos, R. Sinnreich, A.R. Miserez, and J.D. Kark The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood J Pediatr 158 2010 44 50
26. E.S. Ford, and S. Capewell Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates J Am Coll Cardiol 50 2007 2128 2132
27. C. Li, E.S. Ford, P.E. McBride, P.O. Kwiterovich, B.W. McCrindle, and S.S. Gidding Non-high-density lipoprotein cholesterol concentration is associated with the metabolic syndrome among US youth aged 12-19 years J Pediatr 158 2011 201 207
28. S. Mora, M. Szklo, J.D. Otvos, P. Greenland, B.M. Psaty, and D.C. Goff Jr. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 192 2007 211 217
29. C.J. Packard, T. Demant, J.P. Stewart, D. Bedford, M.J. Caslake, and G. Schwertfeger Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions J Lipid Res 41 2000 305 318
30. S.R. Daniels, and F.R. Greer Committee on N. Lipid screening and cardiovascular health in childhood Pediatrics 122 2008 198 208
31. D.I. Chasman, G. Pare, S. Mora, J.C. Hopewell, G. Peloso, and R. Clarke Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis PLoS Genet 5 2009 e1000730
32. S.F. Burns, S.J. Lee, and S.A. Arslanian Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth J Pediatr 161 2012 991 996
33. Beydoun MA, Wang Y. Socio-demographic disparities in distribution shifts over time in various adiposity measures among American children and adolescents: what changes in prevalence rates could not reveal. Int J Pediatr Obes. In press.
34. P.W. Siri-Tarino, P.T. Williams, H.S. Fernstrom, R.S. Rawlings, and R.M. Krauss Reversal of small, dense LDL subclass phenotype by normalization of adiposity Obesity (Silver Spring) 17 2009 1768 1775
35. N. Chainani-Wu, G. Weidner, D.M. Purnell, S. Frenda, T. Merritt-Worden, and C. Pischke Changes in emerging cardiac biomarkers after an intensive lifestyle intervention Am J Cardiol 108 2011 498 507